Janux Therapeutics Balance Sheet
NASDAQ: JANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Janux Therapeutics financial position
At the end of fiscal 2025, Janux Therapeutics reported total assets of $1.00 billion, down 5.6% from a year earlier against total liabilities of $44.7 million. Shareholders' equity stood at $956.8 million, or 95.5% of assets. The company held $52.3 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 39.04, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Janux Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 52.33M | 430.61M | 19.20M | 51.43M | 35.58M | 7.81M |
| Short-Term Investments | 914.23M | 594.57M | 324.82M | 275.59M | 339.38M | 0 |
| Receivables | 0 | — | 0 | 0 | 0 | 8.00M |
| Total Current Assets | 975.89M | 1.03B | 349.24M | 332.44M | 377.02M | 16.06M |
| Property, Plant & Equipment | 3.85M | 4.86M | 7.00M | 7.09M | 1.41M | 155.00K |
| Total Assets | 1.00B | 1.06B | 380.41M | 364.01M | 379.82M | 16.22M |
| Accounts Payable | 4.97M | 4.03M | 2.42M | 2.16M | 2.46M | 428.00K |
| Total Current Liabilities | 25.00M | 17.46M | 13.03M | 16.51M | 12.80M | 3.18M |
| Total Liabilities | 44.74M | 38.73M | 36.06M | 43.27M | 13.50M | 9.23M |
| Shareholders' Equity | 956.82M | 1.02B | 344.35M | 320.74M | 366.33M | -14.64M |
| Retained Earnings | -351.38M | -237.76M | -168.76M | -110.47M | -47.41M | -14.74M |
| Net Cash (Debt) | 966.57M | 1.03B | 344.03M | 327.02M | 374.96M | 7.81M |
| Shares Outstanding | 60.38M | 59.06M | 46.25M | 41.62M | 41.24M | 1.05M |
This table shows 6 annual periods of Janux Therapeutics's balance sheet, from FY 2025 back to FY 2020, across 13 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow JANX's reporting calendar. What is a balance sheet?